10 Best Mid-Cap Healthcare Stocks To Buy Now
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Intra-Cellular Therapies Inc. (ITCI)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 3,000,000 | $205,470,000 | +22% | 2.73% |
| 2. | Perceptive Advisors Joseph Edelman | 1,716,407 | $117,556,715 | +63% | 2.83% |
| 3. | Suvretta Capital Management Aaron Cowen | 1,565,996 | $107,255,066 | +64% | 3.93% |
| 4. | Deep Track Capital David Kroin | 1,537,922 | $105,332,278 | +3% | 3.14% |
| 5. | Holocene Advisors Brandon Haley | 1,479,675 | $101,342,941 | +63% | 0.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.60 | 49,500 | Director | 4,743,770 | 2020-09-14 | Filing | |
| $28.08 | 21,000 | Director | 4,694,270 | 2020-09-11 | Filing | |
| $11.00 | 6,240 | Large Shareholder, Director | 4,673,270 | 2019-09-10 | Filing | |
| $10.58 | 320,095 | Large Shareholder, Director | 4,667,030 | 2019-09-10 | Filing | |
| $9.59 | 155,116 | Large Shareholder, Director | 4,346,935 | 2019-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $73.32 | 6,193 | 1,070,329 | 2024-08-30 | Filing | ||
| $72.73 | 28,203 | 1,076,522 | 2024-08-30 | Filing | ||
| $73.25 | 5,772 | 1,070,329 | 2024-08-29 | Filing | ||
| $72.44 | 29,832 | 1,076,101 | 2024-08-29 | Filing | ||
| $73.70 | 240 | 1,070,329 | 2024-08-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,457,694 | $820,600,049 | 0.06% | |
| 2. | 9,094,302 | $651,333,910 | 0.01% | |
| 3. | 8,193,544 | $586,821,618 | 0.01% | |
| 4. | 3,627,308 | $259,787,799 | 1.43% | |
| 5. | 3,066,400 | $219,615,568 | 3.35% |
News See All
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to Intra-Cellular Therapies Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Funds Like Intra-Cellular Therapies (NASDAQ:ITCI)
The healthcare industry is considered to be a fairly defensive sector due to its need.
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies' First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Best Russell 2000 Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best Russell 2000 stocks to buy.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript
Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc.
16 Best Mid-Cap Growth Stocks To Buy Now
Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...
5 Best Psychedelic Stocks to Buy
COMPASS Pathways plc (NASDAQ:CMPS) is a mental healthcare company based in the United Kingdom.
5 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds.